广州洁特生物过滤股份有限公司关于公司诉讼事项重审一审判决的进展公告

Core Viewpoint - The company is currently involved in a legal dispute with Shenzhen Hosheng Medical Technology Co., Ltd. regarding a mold procurement contract, with a total claim amount of 10,340,829 yuan and additional losses of 644,911 yuan [2][3]. Group 1: Litigation Status - The case is at the stage of retrial in the first instance [2]. - The company is the plaintiff (and counter-defendant) in this litigation [2]. - The company has previously fully provided for bad debts related to the advance payment to Hosheng Medical [2][5]. Group 2: Background of the Litigation - The company filed a lawsuit against Hosheng Medical in August 2022 due to disputes over nine mold procurement contracts signed between November 2020 and January 2021 [3]. - In March 2023, the Huangpu Court ruled to terminate the contracts and ordered Hosheng Medical to refund the payment and compensate for losses, but Hosheng Medical appealed the decision [3]. - In March 2024, the Guangzhou Intermediate People's Court annulled the original ruling and sent the case back for retrial [3]. Group 3: Retrial Judgment - The Huangpu Court recently issued a civil judgment, which includes the termination of the contracts and rejection of the company's other claims, while also dismissing all claims from Hosheng Medical [4]. - The company is responsible for the litigation costs amounting to 87,131.24 yuan for the main case and 5,000 yuan for litigation preservation [4]. Group 4: Future Implications - The company plans to appeal the recent judgment, but it is currently unable to estimate the impact on its profits for the current and future periods [5]. - The company will continue to monitor the case's progress and fulfill its information disclosure obligations [5].